Question 1

What specific benefits could the [18F] fluciclovine PET/MRI provide for my treatment planning?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI clinical trial (NCT03264456). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this imaging method compare to traditional imaging techniques I might have already undergone?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI clinical trial (NCT03264456). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects associated with the [18F] fluciclovine PET/MRI?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI clinical trial (NCT03264456). Contact the study team or your healthcare provider for specific answers.

Question 4

How will the results of this imaging affect my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI clinical trial (NCT03264456). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the process for scheduling and undergoing the PET/MRI scan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI clinical trial (NCT03264456). Contact the study team or your healthcare provider for specific answers.

Question 6

How long does the imaging session take, and what should I expect during the procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI clinical trial (NCT03264456). Contact the study team or your healthcare provider for specific answers.

What this study is about